Evidence-Based Medicine Guidelines
Cholinesterase inhibitors for mild cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cholinesterase Inhibitors for Mild Cognitive Impairment." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment.
Cholinesterase inhibitors for mild cognitive impairment. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment. Accessed March 12, 2025.
Cholinesterase inhibitors for mild cognitive impairment. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment
Cholinesterase Inhibitors for Mild Cognitive Impairment [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cholinesterase inhibitors for mild cognitive impairment
ID - 458192
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
